Triple-negative breast cancer (TNBC), a breast cancer subtype characterized by lack of estrogen and progesterone receptor expression and absence of EGFR-2 (HER2/erbB2) overexpression, accounts for 15–20% of all breast cancers and most commonly affects young women under the age of 45. This evidence concerns the gene ERBB2 and breast cancer.